NCT03329950 2024-03-28
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Celldex Therapeutics
Phase 1 Completed
Celldex Therapeutics
Institut Paoli-Calmettes
Instituto do Cancer do Estado de São Paulo